11 research outputs found
InGaN µLEDs integrated onto colloidal quantum dot functionalized ultra-thin glass.
Red-, orange-, and green-emitting integrated optoelectronic sources are demonstrated by transfer printing blue InGaN µLEDs onto ultra-thin glass platforms functionally enhanced with II-VI colloidal quantum dots (CQDs). The forward optical power conversion efficiency of these heterogeneously integrated devices is, respectively, 9%, 15%, and 14% for a blue light absorption over 95%. The sources are demonstrated in an orthogonal frequency division multiplexed (OFDM) visible light communication link reaching respective data transmission rates of 46 Mbps, 44 Mbps and 61 Mbps.EPSRC grant EP/K00042X/1. DJ Wallis also acknowledges the support of EPSRC grant EP/N01202X/1
Towards 10 Gb/s orthogonal frequency division multiplexing-based visible light communication using a GaN violet micro-LED
Visible light communication (VLC) is a promising solution to the increasing demands for wireless connectivity. Gallium nitride micro-sized light emitting diodes (micro-LEDs) are strong candidates for VLC due to their high bandwidths. Segmented violet micro-LEDs are reported in this work with electrical-to-optical bandwidths up to 655 MHz. An orthogonal frequency division multiplexing-based VLC system with adaptive bit and energy loading is demonstrated, and a data transmission rate of 11.95 Gb/s is achieved with a violet micro-LED, when the nonlinear distortion of the micro-LED is the dominant noise source of the VLC system. A record 7.91 Gb/s data transmission rate is reported below the forward error correction threshold using a single pixel of the segmented array when all the noise sources of the VLC system are present.Engineering and Physical Sciences Research Council (EPSRC) (EP/K00042X/1, EP/M506515/1)
Thigh-length compression stockings and DVT after stroke
Controversy exists as to whether neoadjuvant chemotherapy improves survival in patients with invasive bladder cancer, despite randomised controlled trials of more than 3000 patients. We undertook a systematic review and meta-analysis to assess the effect of such treatment on survival in patients with this disease